# Clinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid Leukemia

> **NCT07263906** · PHASE1 · RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 48 (estimated)

## Conditions studied

- Refractory Acute Myeloid Leukemia
- Recurrent Acute Myeloid Leukemia

## Interventions

- **BIOLOGICAL:** Anti-LILRA6 CAR-T cells

## Key facts

- **NCT ID:** NCT07263906
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2027-10-01
- **Final completion:** 2028-10-01
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07263906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07263906, "Clinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07263906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*